Ten years ago, an 18-year-old student named Jesse Gelsinger died during a medical research trial involving gene therapy at the University of Pennsylvania. The teenager’s death, caused by a violent immune reaction to an injection, triggered a federal inquiry, a review of human protection standards in clinical trials and, ultimately, tougher national standards for patient consent.
By Jeanne Lenzer and Shannon Brownlee
28 October 2009
